395 related articles for article (PubMed ID: 30327561)
1. Structural insights into binding specificity, efficacy and bias of a β
Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK
Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561
[TBL] [Abstract][Full Text] [Related]
2. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor.
Green SA; Spasoff AP; Coleman RA; Johnson M; Liggett SB
J Biol Chem; 1996 Sep; 271(39):24029-35. PubMed ID: 8798639
[TBL] [Abstract][Full Text] [Related]
3. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
Feng Z; Hou T; Li Y
J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
[TBL] [Abstract][Full Text] [Related]
4. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
5. Membrane-Facilitated Receptor Access and Binding Mechanisms of Long-Acting
Szlenk CT; Gc JB; Natesan S
Mol Pharmacol; 2021 Oct; 100(4):406-427. PubMed ID: 34334369
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domains.
Baker JG; Proudman RG; Hill SJ
Mol Pharmacol; 2015 Jan; 87(1):103-20. PubMed ID: 25324048
[TBL] [Abstract][Full Text] [Related]
7. An allosteric modulator binds to a conformational hub in the β
Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
[TBL] [Abstract][Full Text] [Related]
8. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
9. Structural features of β2 adrenergic receptor: crystal structures and beyond.
Bang I; Choi HJ
Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
[TBL] [Abstract][Full Text] [Related]
10. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
[TBL] [Abstract][Full Text] [Related]
11. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.
Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK
Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936
[TBL] [Abstract][Full Text] [Related]
12. An insilico approach to high altitude pulmonary edema - Molecular modeling of human beta2 adrenergic receptor and its interaction with Salmeterol & Nifedipine.
Chandramoorthi GD; Piramanayagam S; Marimuthu P
J Mol Model; 2008 Sep; 14(9):849-56. PubMed ID: 18512086
[TBL] [Abstract][Full Text] [Related]
13. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist.
Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
15. Visualization of arrestin recruitment by a G-protein-coupled receptor.
Shukla AK; Westfield GH; Xiao K; Reis RI; Huang LY; Tripathi-Shukla P; Qian J; Li S; Blanc A; Oleskie AN; Dosey AM; Su M; Liang CR; Gu LL; Shan JM; Chen X; Hanna R; Choi M; Yao XJ; Klink BU; Kahsai AW; Sidhu SS; Koide S; Penczek PA; Kossiakoff AA; Woods VL; Kobilka BK; Skiniotis G; Lefkowitz RJ
Nature; 2014 Aug; 512(7513):218-222. PubMed ID: 25043026
[TBL] [Abstract][Full Text] [Related]
16. Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.
Bai Q; Zhang Y; Ban Y; Liu H; Yao X
PLoS One; 2013; 8(7):e68138. PubMed ID: 23922653
[TBL] [Abstract][Full Text] [Related]
17. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of β
Liu X; Masoudi A; Kahsai AW; Huang LY; Pani B; Staus DP; Shim PJ; Hirata K; Simhal RK; Schwalb AM; Rambarat PK; Ahn S; Lefkowitz RJ; Kobilka B
Science; 2019 Jun; 364(6447):1283-1287. PubMed ID: 31249059
[TBL] [Abstract][Full Text] [Related]
19. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Tang H; Wang XS; Hsieh JH; Tropsha A
Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
